Adipose-Derived Stem Cells Improve Renal Function in a Mouse Model of IgA Nephropathy
- Authors
- Hyun, Young Youl; Kim, In Ok; Kim, Mi Hyung; Nam, Deok Hwa; Lee, Mi Hwa; Kim, Jung Eun; Song, Hye Kyoung; Cha, Jin Joo; Kang, Young Sun; Lee, Ji Eun; Kim, Hyun Wook; Han, Jee Young; Cha, Dae Ryong
- Issue Date
- 2012
- Publisher
- SAGE PUBLICATIONS INC
- Keywords
- Adipose-derived stem cells (ASCs); HIGA mice; Th1 cytokine; Glomerulosclerosis; Proteinuria
- Citation
- CELL TRANSPLANTATION, v.21, no.11, pp.2425 - 2439
- Indexed
- SCIE
SCOPUS
- Journal Title
- CELL TRANSPLANTATION
- Volume
- 21
- Number
- 11
- Start Page
- 2425
- End Page
- 2439
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/109323
- DOI
- 10.3727/096368912X639008
- ISSN
- 0963-6897
- Abstract
- T-cell dysregulation plays an important role in the pathogenesis of immunoglobulin A nephropathy (IgAN). Adipose-derived stem cells (ASCs) have been reported to be able to prevent tissue damage through immune-modulating effects. To evaluate the effects of ASCs in high IgA ddY (HIGA) mice, ASCs were isolated from HIGA mice with different stages of IgAN before and after disease onset. ASCs were injected at a dose of 5 x 10(6) cells/kg body weight through the tail vein every 2 weeks for 3 months. Although the administered ASCs were rarely detected in the glomeruli, 24-h proteinuria was markedly decreased in all ASC-treated groups. Although glomerular deposition of IgA was not significantly different among groups, mesangial proliferation and glomerulosclerosis were dramatically decreased in most ASC treatment groups. In addition, levels of fibrotic and inflammatory molecules were markedly decreased by ASC treatment. Interestingly, ASC therapy significantly decreased Th1 cytokine activity in the kidney and caused a shift to Th2 responses in spleen T-cells as determined by FACS analysis. Furthermore, conditioned media from ASCs abrogated aggregated IgA-induced Th1 cytokine production in cultured HIGA mesangial cells. These results suggest that the beneficial effects of ASC treatment in IgAN occur via paracrine mechanisms that modulate the Th1/Th2 cytokine balance. ASCs are therefore a promising new therapeutic agent for the treatment of IgAN.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.